Speakers

Nicole Gormley, MD
Acting Division Director
for the Division of Hematologic Malignancies II
FDA
Albert Kraus, PhD
Global Regulatory
Portfolio Lead, Oncology
Pfizer
Amanda Bruno, PhD
VP and Head, RWE Oncology
Bayer
Chris Boshoff, MD, PhD, FMedSci
Chief Development Officer for Oncology
Pfizer
Clara Chen, PhD, MS
Director, WWHEOR Lead Hematology
Bristol-Myers Squibb
David Martin, MD, MPH
Associate Director for RWE Analytics, Office of Medical Policy, CDER
FDA
Eric Ammann, PhD
Associate Director,
Real World Research
Janssen
Isao Kamae, MD, DrPH
Project Professor of Health Policy and Technology Assessment Graduate School of Public Policy
The University of Tokyo
Jeff Allen, PhD
President and CEO
Friends of Cancer Research
Jeff Venstrom, MD
SVP, Head of Clinical Development
Foundation Medicine
Kara Kilpatrick, MPH
Global Regulatory and R&D Policy Director
Amgen
Katherine Tsokas, JD
Regulatory Head of Regenerative Medicine & Advanced Therapy and Interim Lead of GRA Data Science
Janssen
Katherine Winfree, PhD
Senior Research Scientist, Global Patient Outcomes and Real World Evidence
Eli Lilly
Kiran Patel, MD
Vice President, Clinical Development, Solid Tumor
Janssen
Lihua Yu, PhD
President & Chief Data Science Officer
H3 Biomedicine
Mark Sculpher, PhD
Professor of Health Economics, Centre for Health Economics
University of York
Mathias Hukkelhoven, PhD
SVP, Global Regulatory, Safety & Biometrics
Bristol-Myers Squibb
Maura Dickler, MD
VP, Oncology Late Phase Development
Eli Lilly
Michael A. Kelsh, PhD, MPH
MPH Executive Firector, Oncology Therapeutic Area Lead, Center for Observational Research (CfOR) Amgen
Michael Taylor, PhD
Global Head, RWD Collaboration
Genentech / Roche
Yousuf Zafar, MD, MHS, FASCO
Associate Professor of Medicine, Public Policy, & Population Science
Duke Cancer Institute
Dominik Heinzmann, PhD
Global Head of PHC Data Science Oncology, Solid Tumors Franchises
Roche
Nahleen Lopez, PharmD, MS-HCA, MS-HCA, GWCPM
Senior Program Management Officer, Real World Evidence Analytics Staff
FDA
Páll Jónsson, PhD
Associate Director Science Policy and Research
National Institute for Health and Care Excellence (NICE)
Xavier Kurz, MSc, PhD
Head of Surveillance & Epidemiology, Data Analysis and Methods Taskforce
European Medicines Agency
(remote speaker)
Ravi Parikh, MD
Instructor in Medical Ethics & Health Policy, Staff Physician,
University of Pennsylvania
Corporal Michael J. Crescenz
VA Medical Center
Razelle Kurzrock, MD
Director, Center for Personalized Caner Therapy & Rare Tumor Clinic
UCSD Moores Cancer Center
Ron Park, MD
VP Global Product Strategy, Head for Personalized Healthcare
Genentech / Roche
Scott Huntington, MPH, MD
Assistant Professor of Medicine, Yale University
Scott Ramsey, MD, PhD
Director, Hutchinson Institute for Cancer Outcomes Research
Fred Hutchinson Cancer Center
Wei Zhou, MD, PhD
Executive Director, Center for Observational and RWE
Merck
Winson Cheung, MD, MPH
Professor of Medicine,
University of Calgary
Expert Review Committee Member
pCODR CADTH
Yanyu Wu, PhD
Associate Director, Global Outcomes Research and Epidemiology, Oncology
Takeda
Pallavi Mishra-Kalyani, PhD
Leader in the Division of Biometrics V, Office of Biostatistics
CDER, FDA
Laleh Amiri-Kordestani, MD
Associate Division Director
FDA
Harpreet Singh, MD
Director (Acting) of the Division of Oncology 2 with the Office Oncologic Diseases
FDA
Nate Gosselin
Director, Product Management
Flatiron Health
Nicole Mahoney, PhD
Senior Director, Regulatory Policy
Flatiron Health
Morgan Romine, MPA
Policy Fellow for Strategic Engagement
Duke Margolis Center for Health Policy
Rebecca Miksad, MD
Senior Medical Director
Flatiron Health
Robert Kalesnik-Orszulak, PharmD
Associate Director, Global Regulatory Strategy
Bristol-Myers Squibb
Zach Weinberg
Co-Founder, President and COO
Flatiron Health
Somnath Sarkar, PhD, MSc
Vice President,
Head of Quantitative Sciences
Flatiron Health
Shrujal Baxi, MD
Senior Medical Director
Flatiron Health
Alex Deyle
Senior Principal,
Life Sciences Partnerships
Flatiron Health
Aracelis Torres, MPH, PhD
Director, Quantitative Sciences
Flatiron Health
Ariel Bourla, MD, PhD
Medical Director
Flatiron Health
Blythe Adamson, PhD, MPH
Principal Quantitative Scientist
Flatiron Health
Christina Parrinello, PhD, MPH
Senior Quantitative Scientist
Flatiron Health
Emily Castellanos, MD
Medical Director
Flatiron Health
Jillian Motyl Rockland, MPH
Senior Manager, Regulatory Solutions
Flatiron Health
Meghna Samant, PhD
Senior Director,
Quantitative Sciences
Flatiron Health
Michael Vasconcelles, MD
Chief Medical Officer
Flatiron Health
Neal Meropol, MD
Vice President, Research Oncology
Flatiron Health
Shane Woods, PhD
Vice President, Life Sciences Partnerships
Flatiron Health

Contact Us

Please contact us using the form below if you have a question.

Thank you! Someone from our team will be in touch.

Oops! Something went wrong while submitting the form :(